In a rat model for depression the experimental reduction of bicc1 mRNA, including the reduction through treatment with the antidepressant ketamine, significantly diminished depressive behaviors in the animals (Ota et al., 2015). This evidence concerns the gene BICC1 and major depressive disorder.